Search tool

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in...

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in...

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in...

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in...

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in...

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in...

The report on the state of the drugs problem in Europe presents the EMCDDA's yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in...

The extent and nature of problems found within populations of European cannabis consumers remain unclear. Also unclear is the extent to which statistical information on increasing demands for treatment reflects changes in...

The co-occurrence of psychiatric illness and substance disorders, commonly termed co-morbidity or dual diagnosis, is not a new phenomenon. However, in recent years the issue has gained momentum in the political and...

Many countries have recently adopted a ‘national drugs strategy’. This Selected issue focuses on plans for the evaluation of these strategies, which for the first time has been enabled on a European...